Video

Q&A With Mary Norine Walsh From St. Vincent Hospital: New Therapies Provide Hope for Heart Failure Patients

Author(s):

With the introduction of two new medications cardiologists have powerful new tools to use in order to help heart failure become an even more manageable condition.

With the introduction of two new medications cardiologists have powerful new tools to use in order to help heart failure become an even more manageable condition.

Mary Norine Walsh, MD, from St. Vincent Hospital in Indianapolis discussed these new options as well as other areas of interest for the condition during the European Society of Cardiology's annual conference in London. In addition to her duties at the hospital Walsh also serves as the Vice President of the American College of Cardiology.

Whether it is the general practitioner, the cardiologist, or the cardiac surgeon, the landscape of heart failure treatment is constantly changing. Because of this learning remains an important factor in daily practice.

New medications and treatments for heart failure have been developed over the past couple of decades but there is still more work to be done. This includes improving existing technology and also adding new tools in the fight against the condition.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
© 2024 MJH Life Sciences

All rights reserved.